Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2000
12/26/2000US6165471 Homogeneous human papillomavirus capsomere containing compositions, methods for manufacture, and use thereof as diagnostic, prophylactic or therapeutic agents
12/26/2000US6165470 Hybrid macromolecules composed of albumin derivatives coupled to derivatives of the cd4 receptor having a normal or a higher affinity for the hiv-1 virus.
12/26/2000US6165468 Antigenic carbohydrate linked to an immunogenic carrier
12/26/2000US6165462 Sugar kinase
12/26/2000US6165447 Synergistic combination of about 0.003 to about 2.0% by weight triclosan and about 0.003 to about 2.0% by weight of a mixture of hexahydrocolupulone and hexahydrolupulone.
12/26/2000CA2182476C Macrocyclic difluorostatone derivatives useful as antiviral agents
12/26/2000CA2150671C Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections
12/26/2000CA2014885C 6,11-dihydro-5h-pyrido[2,3-b][1,5]benzodiazepin-5-ones and thiones and their use in the prevention or treatment of aids
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077246A2 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077216A2 Porcine circovirus vaccine in recombinant poxvirus
12/21/2000WO2000077206A2 The myostatin gene promoter and inhibition of activation thereof
12/21/2000WO2000077198A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077191A1 Tumor necrosis factor related receptor, tr6
12/21/2000WO2000077188A2 Dna pcv vaccine
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077043A2 Dna vaccines for pets and sport animals
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077020A1 Novel compounds derived from nucleosides, preparation methods and pharmaceutical compositions containing same
12/21/2000WO2000077019A1 Novel compounds derived from carrageenan, preparation methods and pharmaceutical compositions containing same
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077017A1 Novel amorphous form of clarithromycin
12/21/2000WO2000077016A1 DERIVATIVES OF 4'-DEMYCAROSYL-8a-AZA-8a-HOMOTYLOSIN
12/21/2000WO2000077003A1 Optically active pyrrolopyridazine compounds
12/21/2000WO2000076993A1 Benzazepine derivatives, process for the preparation of the same and uses thereof
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076962A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000WO2000076961A1 Inhibitors of aspartyl protease
12/21/2000WO2000076587A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000WO2000076556A2 High dose radionuclide complexes for bone marrow suppression
12/21/2000WO2000076550A2 Carrier-drug conjugate
12/21/2000WO2000076541A1 Pneumococcal surface protein combination vaccine
12/21/2000WO2000076540A2 Streptococcus pneumoniae proteins and vaccines
12/21/2000WO2000076537A2 Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076528A2 Pharmaceutical preparation containing proteins
12/21/2000WO2000076527A2 New molecular complexes presenting high affinity binding with respect to monocyte derived cells and their uses in therapy
12/21/2000WO2000076521A1 Antiviral indoleoxoacetyl piperazine derivatives
12/21/2000WO2000076520A1 Antifungal oral composition containing itraconazole and process for preparing same
12/21/2000WO2000076519A1 Sulfonamide and sulfamide substituted imidazoquinolines
12/21/2000WO2000076518A1 Urea substituted imidazoquinolines
12/21/2000WO2000076517A1 Il-8 receptor antagonists
12/21/2000WO2000076516A1 Il-8 receptor antagonists
12/21/2000WO2000076515A1 Il-8 receptor antagonists
12/21/2000WO2000076505A1 Amide substituted imidazoquinolines
12/21/2000WO2000076503A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000WO2000076501A1 Il-8 receptor antagonists
12/21/2000WO2000076495A1 Il-8 receptor antagonists
12/21/2000WO2000076478A1 Controlled release and taste masking oral pharmaceutical compositions
12/21/2000WO2000076470A1 Synergistic antibacterial combination
12/21/2000WO2000076457A2 Il-8 receptor antagonists
12/21/2000WO2000047227A3 Mycobacterium tuberculosis, immunization
12/21/2000WO2000045791A3 Method for controlling liposome size
12/21/2000WO2000045167A3 Non-invasive method for detecting target rna
12/21/2000WO2000044710A3 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
12/21/2000WO2000044709A3 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
12/21/2000WO2000042068A3 Hiv related peptides
12/21/2000WO2000038660A3 Use of bisphosphonates for the prevention and treatment of infectious processes
12/21/2000WO2000032201A3 Use of 17-ketosteroids for the treatment of malaria and trypanosomiasis
12/21/2000DE19927740A1 Preparing an agent for diagnosis or control of microbial infection, useful particularly against Helicobacter, based on identification of essential genes in defective mutants
12/21/2000CA2391364A1 47 human secreted proteins
12/21/2000CA2391361A1 47 human secreted proteins
12/21/2000CA2390946A1 49 human secreted proteins
12/21/2000CA2383048A1 49 human secreted proteins
12/21/2000CA2382769A1 42 human secreted proteins
12/21/2000CA2382748A1 50 human secreted proteins
12/21/2000CA2382743A1 48 human secreted proteins
12/21/2000CA2382735A1 49 human secreted proteins
12/21/2000CA2380860A1 Benzazepine derivative, production and use thereof
12/21/2000CA2379327A1 Pneumococcal surface protein combination vaccine
12/21/2000CA2377431A1 Antibody-based treatment for streptococcus pneumoniae infection
12/21/2000CA2377397A1 Il-8 receptor antagonists
12/21/2000CA2377391A1 Il-8 receptor antagonists
12/21/2000CA2377386A1 Il-8 receptor antagonists
12/21/2000CA2377341A1 Il-8 receptor antagonists
12/21/2000CA2377153A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2
12/21/2000CA2376851A1 Synergistic antibacterial combination
12/21/2000CA2376717A1 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000CA2376523A1 Dna pcv-vaccine
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376296A1 Urea substituted imidazoquinolines
12/21/2000CA2375848A1 Optically active pyrrolopyridazine compounds
12/21/2000CA2375812A1 Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin
12/21/2000CA2375320A1 Dna vaccines for pets or for animals used in sports
12/21/2000CA2374555A1 Thiol derivative, metallo-beta-lactamase inhibitors
12/21/2000CA2340663A1 Antiviral indoleoxoacetyl piperazine derivatives
12/20/2000EP1061085A2 Synthetic catalytic oligonucleotides
12/20/2000EP1060745A2 A composition and method for treating bacterial infection
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060188A1 Cholenic acid amides and pharmaceutical compositions thereof
12/20/2000EP1060182A2 Novel prodrugs for phosphorus-containing compounds
12/20/2000EP1060180A1 Process for synthesizing carbapenem antibiotics
12/20/2000EP1060179A1 Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
12/20/2000EP1060162A1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
12/20/2000EP1059936A1 Il-12 stimulation of neonatal immunity
1 ... 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 ... 1798